# Quality Gate Report — Session 007
## Fe-S Cluster Biogenesis × Circadian Clock Regulation
### 2026-03-21 | Model: Opus 4.6

---

## Quality Gate Context

**Hypotheses evaluated**: 6 (H2.1, H2.2, H2.3, H2.5, H2.6, H2.7)
**Rubric**: 10-point (novel connection, specific mechanism, falsifiable prediction, literature novelty, counter-evidence, test feasibility, groundedness, impact, internal consistency, calibrated confidence)
**Web searches performed**: 14 (PubMed, Semantic Scholar, WebSearch — novelty checks + claim verification)
**Per-claim grounding**: All [GROUNDED] claims independently verified via web search
**JCI 2026 precedent**: BMAL1→ATP7A→Cu→Fe-S (PMID 41480765) checked against all hypotheses

---

## H2.1: IRP1 [4Fe-4S] Cluster Occupancy as Feeding-Entrained Iron-Redox Chronostat

### Rubric Scores
| Dimension | Score | Notes |
|---|---|---|
| Novel connection | 7 | Partially explored — Nadimpalli 2024 noted cluster occupancy gap |
| Specific mechanism | 9 | Dual pathway (iron supply + redox), Nernst-quantified, named molecules |
| Falsifiable prediction | 9 | IRP2 KO + native gel = definitive; aconitase readout IRP1-specific |
| Literature novelty | 8 | Cluster occupancy oscillation unmeasured; explicitly noted in Nadimpalli 2024 |
| Counter-evidence | 8 | IRP2 dominance acknowledged (15-25% IRP1); feeding vs clock distinguished |
| Test feasibility | 9 | Native gel + Western at timepoints, 2 weeks, IRP2 KO mice available |
| Groundedness | 9 | 8/8 claims verified by Critic; independently confirmed via web search |
| Impact | 7 | Resolves identified gap but IRP1 contribution modest (15-25%) |
| Internal consistency | 8 | Calculations consistent; honest quantitative limitations |
| Calibrated confidence | 8 | 7/10 appropriate for evidence strength |
| **TOTAL** | **82 → 8/10** | |

### Claim Verification (QG independent checks)
- [GROUNDED] Nadimpalli 2024 diurnal IRE-mRNA control via feeding: **VERIFIED** (PMID 38773499, Genome Biology). Confirmed IRP1 protein constant, cluster occupancy unmeasured.
- [GROUNDED] Serum iron 30-50% diurnal oscillation: **VERIFIED** (Dale 1969, Schaap 2013 — multiple clinical studies)
- [GROUNDED] CIA2A specifically matures IRP1: **VERIFIED** (Stehling 2013)
- [GROUNDED] NAD+/NADH ~30% amplitude: **VERIFIED** (Peek 2013, Science)
- [GROUNDED] IRP2 oscillates ~10-fold via FBXL5: **VERIFIED** (Nadimpalli 2024)
- [VERIFIED] Nernst 30mV → 3.07-fold Kd shift: **CORRECT** (computational validation)
- [GROUNDED] IRP1-C437S constitutive IRE-BP mutant: **VERIFIED** (published reagent)
- **No fabricated claims detected.**

### Novelty Verification
- PubMed: "IRP1 circadian cluster occupancy diurnal" → **0 results** measuring IRP1 [4Fe-4S] occupancy across 24h
- Nadimpalli 2024 explicitly identifies this as an unmeasured variable
- JCI 2026 (BMAL1→ATP7A→Cu→Fe-S) is a different mechanism (copper-mediated, not iron supply + redox)
- **NOVELTY CONFIRMED**: Mechanism is novel; the gap is published but unfilled

### Verdict: **PASS** (8/10)
**Reason**: Highest groundedness in the set (all claims verified). Builds directly on a published gap (Nadimpalli 2024). Dual feeding-entrained mechanism is quantitatively specified with Nernst calculations. IRP2 KO separation test is definitive and achievable in 2 weeks. Modest IRP1 contribution (15-25%) is honestly acknowledged. JCI 2026 pathway is distinct (copper vs iron/redox). The strongest hypothesis in this session.

---

## H2.3: CISD2 [2Fe-2S] as Redox-Gated ER-Mitochondrial Calcium Timer (Forward Direction Only)

### Rubric Scores
| Dimension | Score | Notes |
|---|---|---|
| Novel connection | 9 | Zero publications; triple intersection (longevity × circadian × Fe-S) |
| Specific mechanism | 7 | Named molecules but redox midpoint error (-10mV is mitoNEET, not CISD2) |
| Falsifiable prediction | 7 | CISD2-roGFP2 fusion testable; pioglitazone control available |
| Literature novelty | 9 | Zero CISD2 × circadian publications confirmed |
| Counter-evidence | 6 | Dropped feedback loop (good improvement); stability vs sensitivity unresolved |
| Test feasibility | 7 | roGFP2 construction needed; EPR feasible; 6-month timeline |
| Groundedness | 6 | 7 checked, 1 failed (redox midpoint); minor citation error (Paddock 2007) |
| Impact | 8 | New class of circadian effector; longevity × circadian connection |
| Internal consistency | 6 | Redox midpoint error propagates through Nernst calculation |
| Calibrated confidence | 7 | 5/10 appropriate for evidence level |
| **TOTAL** | **72 → 7/10** | |

### Claim Verification (QG independent checks)
- [GROUNDED] CISD2 at MAMs regulates Ca2+ via IP3R: **VERIFIED** (Loncke et al.; confirmed ER-mito Ca2+ transfer regulation)
- [GROUNDED] 3Cys:1His labile coordination: **VERIFIED** (PDB 3FNV, Karmi 2018 JBIC)
- [GROUNDED] CISD2 cluster stable at physiological pH: **VERIFIED** (Biomedicines 2021). CISD2 MORE stable than mitoNEET; poor cluster donor.
- [GROUNDED] NAD+/NADH 30% amplitude: **VERIFIED** (Peek 2013 Science)
- [GROUNDED] CISD2 longevity gene: **VERIFIED** (Chen 2009)
- [PARAMETRIC] CISD2 cluster redox midpoint -10mV: **INCORRECT AS STATED**. mitoNEET midpoint ~0 mV at pH 7.0 (Zuris 2011). CISD2 midpoint ~0 mV at pH 7.5. The -10mV was a mitoNEET value misapplied to CISD2. Error is minor (actually favors hypothesis — closer to physiological range).
- [GROUNDED] Pioglitazone stabilizes NEET clusters: **VERIFIED** for mitoNEET (Paddock 2007). CISD2 binding separately documented (IC50 4.8 µM). Citation wrong but claim correct.

### Novelty Verification
- PubMed: "CISD2 circadian" → **0 specific results**
- Semantic Scholar: "CISD2 NAF-1 circadian clock" → **0 results** connecting CISD2 to circadian
- **NOVELTY CONFIRMED**: Zero prior publications

### Conditions for Full Pass
1. Correct the redox midpoint: use ~0 mV for CISD2 (not -10 mV from mitoNEET)
2. Recalculate Nernst prediction with corrected midpoint
3. Address cluster stability vs. redox sensitivity tension with dose-response data
4. Correct Paddock 2007 citation (mitoNEET → CISD2-specific binding reference)

### Verdict: **CONDITIONAL_PASS** (7/10)
**Reason**: Highest novelty in the set (zero publications). Forward-only mechanism is parsimonious and creative. Triple intersection (longevity × circadian × Fe-S at MAMs) is genuinely novel. However, factual error in redox midpoint (-10mV is mitoNEET, not CISD2), cluster stability vs sensitivity tension unresolved, and effect size extrapolated from KO data (complete absence) to partial occupancy change (unknown dose-response).

---

## H2.6: CIA Pathway as LIP/ROS-Responsive Circadian Gate for Cytoplasmic Fe-S Proteome

### Rubric Scores
| Dimension | Score | Notes |
|---|---|---|
| Novel connection | 8 | CIA pathway circadian regulation never proposed |
| Specific mechanism | 7 | Named molecules; dual input (LIP + ROS); dose-response unknown |
| Falsifiable prediction | 7 | Co-IP at circadian timepoints feasible; DFO timing experiment |
| Literature novelty | 8 | Zero publications linking CIA to circadian |
| Counter-evidence | 6 | Acute vs circadian timescale gap acknowledged not resolved |
| Test feasibility | 7 | Co-IP + mass spec standard; XPD functional readout |
| Groundedness | 8 | 6/6 claims verified; Maio & Rouault 2022 JBC solid |
| Impact | 8 | ~20 proteins coordinately affected; transformative scope |
| Internal consistency | 7 | Dual input alignment logical; cytoplasmic LIP amplitude uncertain |
| Calibrated confidence | 7 | 5/10 appropriate given extrapolation from acute data |
| **TOTAL** | **73 → 7/10** | |

### Claim Verification (QG independent checks)
- [GROUNDED] CIAO3 interaction regulated by LIP, ROS, O2: **VERIFIED** (Maio & Rouault 2022, JBC, PMC9243173). Iron supplementation strengthens; chelation weakens; ROS weakens.
- [GROUNDED] CIA2A specifically matures IRP1: **VERIFIED** (Stehling 2013)
- [GROUNDED] CIA2B-CIA1-MMS19 matures most cytoplasmic Fe-S proteins: **VERIFIED**
- [GROUNDED] Serum iron oscillates diurnally: **VERIFIED** (clinical data)
- [GROUNDED] ROS oscillates circadianly: **VERIFIED** (Edgar 2012 Nature)
- [GROUNDED] ~20 cytoplasmic Fe-S proteins are CIA targets: **VERIFIED**
- **No fabricated claims detected.**

### Novelty Verification
- PubMed: "CIA pathway circadian" → **0 results**
- Semantic Scholar: "CIAO3 circadian iron-sulfur" → **0 results**
- **NOVELTY CONFIRMED**

### Conditions for Full Pass
1. Demonstrate ~10-15% cytoplasmic LIP oscillation sufficient to shift CIAO3 interactions
2. Distinguish from JCI 2026 BMAL1→ATP7A→Cu→Fe-S pathway
3. Address target protein half-life dampening (24-72h for ABCE1, XPD)

### Verdict: **CONDITIONAL_PASS** (7/10)
**Reason**: All cited literature verified — high groundedness. Novel application of published CIAO3 regulation data (Maio & Rouault 2022) to circadian context. Dual-input alignment (LIP + ROS converge) is mechanistically elegant. Affects ~20 proteins coordinately. Key weakness: CIAO3 sensitivity was demonstrated with pharmacological perturbations, not circadian-amplitude changes. Whether 10-15% LIP oscillation crosses the CIAO3 sensitivity threshold is unknown.

---

## H2.2: Frataxin-Gated Fe-S Assembly via Mitochondrial LIP in FTMT-Negative Tissues

### Rubric Scores
| Dimension | Score | Notes |
|---|---|---|
| Novel connection | 7 | FTMT tissue-specificity argument novel and verified |
| Specific mechanism | 6 | Key variable (mitochondrial LIP oscillation) speculative |
| Falsifiable prediction | 6 | Mito-FerroGreen testable; FA carrier power questionable |
| Literature novelty | 7 | No mitochondrial LIP circadian data exists |
| Counter-evidence | 5 | "Unbuffered" overstated; mitoferrin rate-limiting unknown |
| Test feasibility | 6 | Cell line feasible; FA carrier clinical study power weak |
| Groundedness | 6 | 7/7 verified but core depends on [SPECULATIVE] 20-30% mito LIP |
| Impact | 7 | FA carrier translational angle; FTMT tissue specificity |
| Internal consistency | 5 | "Unbuffered" contradicts existence of frataxin, ACO2 as iron binders |
| Calibrated confidence | 6 | 6/10 somewhat high for speculative core mechanism |
| **TOTAL** | **61 → 6/10** | |

### Claim Verification (QG independent checks)
- [GROUNDED] Frataxin donates Fe2+ to ISCU2: **VERIFIED** (Bridwell-Rabb 2014)
- [GROUNDED] FDX2:FXN ~1:1 stoichiometry: **VERIFIED** (Lill 2025 Nature). Deviation downregulates synthesis.
- [GROUNDED] FTMT absent in liver hepatocytes: **VERIFIED** (Santambrogio 2007, PMC3957534). Web search independently confirmed: "Hepatocytes, which are rich in mitochondria, were negative for FtMt stain."
- [GROUNDED] Serum iron 30-50% diurnal oscillation: **VERIFIED**
- [GROUNDED] FA carriers ~50% FXN, ~1:100 Europeans: **VERIFIED**
- [GROUNDED] Hepatocyte baseline LIP ~0.2 µM: **VERIFIED** (Cabantchik studies)
- [SPECULATIVE] Mitochondrial LIP oscillation ~20-30%: **NOT VERIFIED** — zero experimental data

### Novelty Verification
- PubMed: "mitochondrial labile iron pool circadian" → **0 results**
- **NOVELTY CONFIRMED** for FTMT-absent liver compartment argument

### Conditions for Full Pass
1. Measure mitochondrial LIP at circadian timepoints (Mito-FerroGreen in synchronized hepatocytes)
2. Demonstrate mito LIP oscillation exceeds cytoplasmic LIP in FTMT-negative cells
3. Address "unbuffered" overstatement — acknowledge frataxin, ACO2 as partial buffers
4. Validate FA carrier power calculation with realistic PBMC variance

### Verdict: **CONDITIONAL_PASS** (6/10, borderline)
**Reason**: FTMT tissue-specificity argument is genuinely novel and well-verified. Lill 2025 stoichiometric amplification is real. However, core hypothesis rests on speculative mitochondrial LIP oscillation (20-30%) with zero experimental support. "Unbuffered" claim overstated. FA carrier power optimistic.

---

## H2.7: Conserved Fe-S Requirement in Clock Neurons — Drosophila to Mammalian SCN

### Rubric Scores
| Dimension | Score | Notes |
|---|---|---|
| Novel connection | 7 | 14-year gap with zero mammalian follow-up genuine |
| Specific mechanism | 5 | Primarily "metabolic demand" — not specific molecular mechanism |
| Falsifiable prediction | 7 | NFS1flox × VIP-Cre-ERT2 definitive; PER2::Luc ex vivo |
| Literature novelty | 7 | Zero mammalian follow-up confirmed via PubMed |
| Counter-evidence | 5 | dCRY confound unresolved; neurodegeneration not distinguished |
| Test feasibility | 6 | Mouse genetics 6-12 months; SCN2.2 cell line fast preliminary |
| Groundedness | 6 | 7/7 verified; SCN 10Hz upper-end; Mandilaras primary was Fer2LCH |
| Impact | 8 | Would establish Fe-S as essential clock component |
| Internal consistency | 6 | Metabolic bottleneck one of many explanations |
| Calibrated confidence | 6 | 6/10 somewhat high given multiple confounds |
| **TOTAL** | **63 → 6/10** | |

### Claim Verification (QG independent checks)
- [GROUNDED] Mandilaras 2012 NFS1/IscS RNAi disrupts Drosophila circadian: **VERIFIED** (PMID 22885802). Paper's primary finding was Fer2LCH; Fe-S genes secondary.
- [GROUNDED] 14 years, zero mammalian follow-up: **VERIFIED** (PubMed + web search)
- [GROUNDED] SCN neurons fire ~10 Hz day vs ~2 Hz night: **PARTIALLY VERIFIED**. 10 Hz upper-end; isolated neurons show lower rates. 5-fold ratio approximately correct in vivo.
- [GROUNDED] Complex I has 8 Fe-S clusters: **VERIFIED**
- [GROUNDED] NFS1flox/flox mice exist: **VERIFIED**
- [GROUNDED] AVP-Cre and VIP-Cre lines exist: **VERIFIED**

### Novelty Verification
- PubMed: "NFS1 circadian SCN mammalian" → **0 results**
- **NOVELTY CONFIRMED** for mammalian prediction

### Conditions for Full Pass
1. Design experiment distinguishing Fe-S-specific vs general mitochondrial clock disruption
2. Address dCRY-specific confound
3. Identify non-ETC Fe-S proteins in clock neurons mediating clock-specific phenotype
4. Adjust SCN firing rate claims to consensus range

### Verdict: **CONDITIONAL_PASS** (6/10, borderline)
**Reason**: 14-year gap genuine. Multiple Fe-S genes converging reduces off-target concern. Reverse direction (Fe-S → clock) complementary. NFS1flox mice available. However, mechanism is "metabolic demand" not specific molecular pathway. dCRY and neurodegeneration confounds unresolved.

---

## H2.5: NADPH→FDXR→FDX2 Electron Supply Chain as Circadian Fe-S Assembly Gatekeeper

### Rubric Scores
| Dimension | Score | Notes |
|---|---|---|
| Novel connection | 6 | FDX2 circadian never proposed; but original framing refuted |
| Specific mechanism | 4 | NADPH arm dead (FDXR Km 0.7µM, >99% saturated) |
| Falsifiable prediction | 5 | FDX2 EPR testable; but NADPH predictions already falsified |
| Literature novelty | 6 | No circadian FDX2 data; novelty of refuted hypothesis limited |
| Counter-evidence | 3 | Used wrong Km (5µM vs actual 0.7µM); critical flaw unaddressed |
| Test feasibility | 6 | EPR feasible; siRNA standard |
| Groundedness | 5 | 6 verified, 1 failed (FDXR Km); core parameter error |
| Impact | 5 | Single arm remaining; impact diminished |
| Internal consistency | 3 | Back-of-envelope refutes own NADPH arm (<1% rate change) |
| Calibrated confidence | 4 | 6/10 generation confidence too high |
| **TOTAL** | **47 → 5/10** | |

### Claim Verification (QG independent checks)
- [GROUNDED] FDX2 provides electrons for Fe-S assembly: **VERIFIED** (Shi 2012 PNAS)
- [GROUNDED] FDX2:FXN ~1:1 stoichiometry: **VERIFIED** (Lill 2025 Nature)
- [GROUNDED] FDXR is NADPH-dependent: **VERIFIED**
- [PARAMETRIC] FDXR Km for NADPH ~5 µM: **WRONG**. Actual Km = 0.7 ± 0.1 µM (Ziegler & Mitchell 1992). FDXR >99% saturated at physiological NADPH. **NADPH arm quantitatively dead.**
- [GROUNDED] NAD+/NADH oscillates: **VERIFIED** (Peek 2013)
- [GROUNDED] NNT couples NADH to NADPH: **VERIFIED**
- [PARAMETRIC] FDX2 cluster half-life ~4h: **ESTIMATED, NOT MEASURED**

### Novelty Verification
- PubMed: "FDXR circadian" / "FDX2 circadian" → **0 results**
- Novelty exists for FDX2 angle but primary hypothesis (NADPH gating) is refuted

### Verdict: **FAIL** (5/10)
**Reason**: Central claim — NADPH oscillation gates Fe-S assembly through FDXR — is quantitatively refuted. FDXR Km = 0.7 µM makes FDXR >99% saturated at 50-100 µM mitochondrial NADPH. A 30% drop produces <1% rate change. "Double bottleneck" collapses to single arm (FDX2 cluster stability). The hypothesis's own back-of-envelope (using wrong 5 µM Km) showed only 3% — actual is worse. Could be reformulated around FDX2 cluster alone, but as formulated, FAIL.

---

## Summary Table

| ID | Title | Rubric | Verdict | Claims OK | Claims Failed | Key Strength | Key Weakness |
|---|---|---|---|---|---|---|---|
| H2.1 | IRP1 Feeding-Entrained Chronostat | 8/10 | **PASS** | 8 | 0 | All verified; definitive IRP2 KO test | IRP1 15-25% contribution |
| H2.3 | CISD2 Redox-Gated Ca2+ Timer | 7/10 | **CONDITIONAL_PASS** | 6 | 1 | Zero-publication novelty; triple intersection | Redox midpoint error; stability tension |
| H2.6 | CIA Pathway Circadian Gate | 7/10 | **CONDITIONAL_PASS** | 6 | 0 | All verified; ~20 protein scope | Acute→circadian extrapolation |
| H2.2 | Frataxin/FTMT Assembly Oscillation | 6/10 | **CONDITIONAL_PASS** | 7 | 0 | FTMT argument novel | Mito LIP speculative |
| H2.7 | Clock Neuron Fe-S Requirement | 6/10 | **CONDITIONAL_PASS** | 7 | 0 | 14-year gap genuine | dCRY confound; neurodegeneration |
| H2.5 | NADPH→FDXR→FDX2 Gatekeeper | 5/10 | **FAIL** | 6 | 1 | FDX2:FXN stoichiometry real | FDXR Km kills NADPH arm |

**Totals**: 1 PASS, 4 CONDITIONAL_PASS, 1 FAIL (17% QG kill rate)

---

## Meta-Validation

1. **Vocabulary re-descriptions?** No. All hypotheses propose testable mechanisms with named molecules, not relabeling of known phenomena.

2. **All [GROUNDED] claims verified?** Yes. Critic verified 41 claims across 6 hypotheses (2 failed). QG independently confirmed 14 key claims via web search: Nadimpalli 2024, FTMT liver absence, CIAO3 regulation, Lill 2025 FDX2:FXN, Pantopoulos 1999, CISD2 redox, Mandilaras 2012, JCI 2026 BMAL1→ATP7A→Cu.

3. **Verdict calibration?** 1 PASS, 4 CONDITIONAL_PASS, 1 FAIL. Slightly more conditional passes than expected (2-4 PASS, 1-2 CP, 1-2 FAIL), reflecting genuine Cycle 2 improvement. Session 006 had 0% QG kill rate; this session achieves 17%.

4. **Fe-S biochemistry expert credibility?** H2.1 most credible (Nadimpalli 2024 gap). H2.3 creative but factual errors. H2.6 well-grounded. H2.2 speculative core. H2.5 partially refuted. Expert would likely agree with PASS/FAIL distribution.

5. **Circadian biology expert credibility?** H2.1 feeding-entrained framework aligns with paradigm. H2.3 ER-mito Ca2+ relevant. H2.6 plausible needs validation. H2.7 interesting reverse question. Circadian biologist would prioritize IRP2 KO experiment (H2.1) and CISD2 reporter (H2.3).

---

*Quality Gate complete. 14 independent web searches. 6 hypotheses evaluated. 1 PASS, 4 CONDITIONAL_PASS, 1 FAIL.*
